Here, we found that 26% of nonhuman primates infected with Asian/American ZIKV in early gestation experienced fetal demise later in pregnancy despite showing few clinical signs of infection. Pregnancy loss due to asymptomatic ZIKV infection may therefore be a common but under-recognized adverse outcome related to maternal ZIKV infection.
Zika virus (ZIKV) infection is associated with congenital defects and pregnancy loss. Here, we found that 26% of nonhuman primates infected with Asian/American ZIKV in early gestation experienced fetal demise later in pregnancy despite showing few clinical signs of infection. Pregnancy loss due to asymptomatic ZIKV infection may therefore be a common but under-recognized adverse outcome related to maternal ZIKV infection.
Adverse outcomes after ZIKV infection during pregnancy include sensory defects, fetal brain malformations, and pregnancy loss 1, 2 . ZIKV-associated pregnancy loss may be underreported because ZIKV infections are often asymptomatic 3 . There is limited evidence that symptomatic infections with ZIKV and other flaviviruses are associated with miscarriage and stillbirth 1, 2, [4] [5] [6] [7] . A recent study has found a 5.8% miscarriage rate and a 1.6% stillbirth rate in women infected during the first trimester 6 . Because this and many other human studies have characterized fetal loss only in symptomatic women, the rates are likely to be an underrepresentation. Nonhuman primates (NHPs) are physiologically similar to humans, have extensive parallels in the histology and immunology of the maternal-fetal interface 8 , and recapitulate the clinical course of human ZIKV infection [9] [10] [11] [12] . Critically, many ZIKV infections in NHPs do not exhibit substantial clinical signs and therefore closely resemble asymptomatic human ZIKV infections.
We aggregated fetal-loss data collected from ZIKV-infected pregnant NHPs at six National Primate Research Centers (NPRCs) to assess the rate of fetal demise (Supplementary Tables 1 and 3) , including some data from previously published studies [10] [11] [12] [13] [14] [15] . Fetal death was observed in 13 of 50 animals (26.0%), and early neonatal death was observed in an additional three animals ( Supplementary  Tables 1 and 3 ). Frequent fetal loss was found in animals infected with ZIKV isolated from Brazil and/or Puerto Rico (46.7% (n = 15) and 28.6% (n = 35), respectively). The average rates of fetal demise (defined here as fetal death in utero, i.e., spontaneous abortion before planned termination, or stillbirth discovered at planned termination) among comparably housed healthy, ZIKV-unexposed pregnant macaques ranged from 4% to 10.9% (Supplementary Table 2 ). At the three centers providing breeding-colony data from rhesus
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NAture MedIcINe macaques (NPRCs in California (CNPRC), Oregon (ONPRC), and Wisconsin (WNPRC) (n = 2,823 pregnancies), a fourfold increase in the odds of fetal loss was observed for ZIKV-exposed animals (11 losses out of 40 pregnancies) compared with unexposed animals (250 losses out of 2,823 pregnancies) (chi-square odds ratio (OR) = 3.9; 95% confidence interval (CI) = 1.9-7.9; P < 0.0001) (Supplementary Table 2 and Supplementary Figure 1 ). More than half of the fetal-loss cases occurred after mid-gestation (gestational day (GD) > 83, mean = 96 d (range 35-166); Supplementary Table 3 ), a stage in which the natural rate of pregnancy loss in humans is very low at 0.1% (refs 16, 17 ). Finally, baseline fetal demise in pigtail macaques was 10.9% (42/385); however, zero of five ZIKV-infected pigtail macaque pregnancies ended in fetal demise (Supplementary Table 2 and Supplementary Figure 1 ). Gestational day GD <55 (n = 29) n GD >55 (n = 9) n HR = NE P = 0.09 P Fig. 1 | Kaplan-Meier curves comparing survival rates among macaques exposed to ZIKV under different conditions. a, Macaques exposed to ZIKV originating from Brazil (BR; red) or Puerto Rico (PR; black). b, Duration of maternal plasma viremia ≤ 14 d postinfection (black) or duration > 14 d postinfection (red) (WNPRC and CNPRC only). c, Inoculation on or before GD 55 (red) or after GD 55 (black) by subcutaneous (SC) or intraamniotic/ intravenous (IA/IV) injection. NE, not estimable, owing to zero events in one group. d, Inoculation on or before GD 55 (red) or after GD 55 (black) by SC injection only. e, Inoculation on or before GD 55 (red) or after GD 55 (black) by IA/IV injection only. f, Inoculation by IA/IV (red) or SC injection (black) at any gestational age. g, Inoculation by IA/IV (red) or SC injection (black) at GD < 55. There were no fetal losses in either route of injection in the group infected at GD > 55; therefore, the curves are not shown, and P = 1.0. HR (when calculable) and two-sided P values based on log-rank test are reported.
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Survival analyses of fetuses exposed to ZIKV isolates originating from Brazil or Puerto Rico were not statistically different according to comparison of Kaplan-Meier curves (hazard ratio (HR) = 1.17; 95% CI = 0.38-3.61; log-rank test, P = 0.79; Fig. 1a ). All but one animal challenged with ZIKV had detectable plasma viremia, and many animals had viremia detectable beyond the typical 1-14 d seen in nonpregnant macaques 9, 18 (Supplementary Table 3 and https://zika.labkey.com/multisite-fetal-demise.url). In animals from WNPRC and CNPRC, the survival of fetuses or neonates was marginally but not significantly better if the duration of viremia was ≤ 14 d than > 14 d (HR = 1.97, 95% CI = 0.42-9.38, log-rank test, P = 0.39; Fig. 1b ).
The timing of infection was an important predictor of fetal demise in these studies. No cases (0/11) of fetal or neonatal death were observed in macaques inoculated after GD 55, whereas macaques inoculated on or before GD 55 had a significantly elevated fetal-demise rate of 37.8% (n = 37) (Fisher's exact test, P = 0.02). Survival analysis ( Fig. 1c-e ) also showed a significant difference between the survival of fetuses whose dams were infected at GD ≤ 55 versus GD > 55 (log-rank test, P = 0.03). An HR could not be calculated because there were zero deaths in the GD > 55 group. This finding parallels human reports of more significant adverse outcomes in babies exposed to ZIKV during the first trimester 2, 6, 19 . The sex of the fetus was evenly distributed in both fetal-loss and fetal-survival cases ( Supplementary Table 3 ). Finally, the difference in survival of fetuses from macaques subjected to subcutaneous (SC) or intra-amniotic/intravenous (IA/IV) inoculation was not significantly different, with an HR for IA/IV inoculation of 3.75 (95% CI = 0.85-16.55; log-rank test, P = 0.08; Fig. 1f ,g). Although there was no apparent difference between SC-and IA/IV-inoculated groups, many of the animals infected at GD < 55 were inoculated through an IA/IV route.
Necropsies were performed on maternal reproductive/fetal extraembryonic (MR/FE) and fetal tissues. Many fetal-and neonatal-demise cases had detectable ZIKV RNA in the MR/FE and/or fetal tissues ( Supplementary Table 4 and https://zika.labkey.com/ multisite-fetal-demise.url). All but one of the fetal-and neonatalloss cases also showed evidence of inflammation in one or more MR/FE tissues, as described in Supplementary Table 5 and at https:// zika.labkey.com/multisite-fetal-demise.url (some of these data were previously reported) 13 . Histopathology revealed major ocular pathologies (i.e., choroidal coloboma, retinal dysplasia, and hemorrhage in the retina), lung pathologies (i.e., neutrophil, lymphocyte, and erythrocyte infiltration, and amniotic fluid aspiration), and, in one animal, a mild ventricular hemorrhage and mild loss of ependyma in the lateral ventricle of the brain (Supplementary Table 5 ). Three fetal-demise cases were associated with preterm premature rupture of membranes, and one neonatal death case was associated with preterm cervical dilation ( Supplementary Table 3 ). Altogether, these data provide evidence that ZIKV and histopathology were present in the MR/FE tissues and in many of the fetuses with adverse outcomes.
Evidence of placental pathology, including chorioamnionitis, deciduitis, and villitis, has also been found in other macaque studies 14, 20 . Although histopathology does not necessarily indicate dysfunction, Hirsch et al. have directly characterized in vivo placental dysfunction after ZIKV infection in rhesus macaques by using advanced imaging and placental histopathology, and their results suggest that the detected pathology is associated with loss of placental function 14 , akin to observations in human miscarriages [21] [22] [23] . These results thus suggest that the role of placental dysfunction in ZIKV-related fetal loss should be carefully studied in human cohorts.
To monitor the health and growth of the fetuses, we performed weekly ultrasound examinations on many animals. In animals with complete analysis of ultrasound data ( Supplementary Table 5 ), the most common finding was increased placental calcification similar to the findings in Hirsch et al. 14 . One animal showed a slightly lower biparietal diameter and head-circumference measurement ( Supplementary Table 5 ); however, no other significant ultrasound findings explained fetal loss.
Fetal death also occurred in two of two ZIKV-infected common marmosets, whereas the average rate of late-term (88-142 d of gestation) fetal loss in healthy marmosets has been reported to be 4.4% (26 of 596) 24 . In both cases, ZIKV RNA was detectable in both MR/FE and fetal tissues ( Supplementary Table 4 ). Minimal histopathology was noted in the MR/FE or fetal tissues, but one fetus showed evidence of disorganization of the cortical neurons 15 ( Supplementary Table 5 ).
Resources were devoted to infecting pregnant macaques and using historical controls instead of mock-infecting pregnant animals. Nevertheless, it is important to note that nine of nine mockinfected pregnant rhesus macaques (three from ONPRC, three from CNPRC, and three from the Washington NPRC (WaNPRC)) did not show any adverse fetal outcomes, thus suggesting that the experimental manipulations, (i.e., frequent blood draws under sedation, weekly ultrasound imaging, and regular amniocentesis) did not lead to the fetal-loss rate seen in the ZIKV-exposed animals ( Supplementary Table 3 ). Amniocentesis has been performed in some studies to detect ZIKV in the fetal compartment (Supplementary Table 3 ). Although amniocentesis carries a small risk of fetal loss (miscarriage or stillbirth), the rate of fetal loss was not significantly different in animals that did (7/29 = 24.1%) and did not (6/21 = 28.6%) receive amniocentesis (Fisher's exact test, P = 0.75; Supplementary Table 3 ). Among animals receiving amniocentesis, those with fetuses that survived to term had more weekly amniocentesis (average = 11, range 1-18, n = 22) than did those with fetal demise (average = 6, range 2-18, n = 7), thus further suggesting that the amniocentesis procedure did not cause fetal demise.
The reported 6% rate of miscarriage in the Rio de Janeiro cohort of women with symptomatic ZIKV infection is among the highest known for any teratogenic virus 6 . The incidence of miscarriage and stillbirth in women infected with ZIKV during pregnancy is unknown and may depend upon a number of factors including the gestational age at the time of infection, inoculum, viral strain, maternal age, and other non-ZIKV co-infections/comorbidities 2 . The high rates of fetal loss among ZIKV-infected NHP pregnancies reported here (26%) raises the concern that ZIKV-associated pregnancy loss in humans may be more frequent than currently thought. The possibility that fetal loss may be more prominent than other congenital defects in the NHP model is concordant with observations from mice, thus further underscoring the value of animal models to identify outcomes that are difficult to identify in humans.
These results, along with recent reports of increased fetal loss in human ZIKV studies, suggest that careful monitoring of fetal loss and stillbirth is warranted. Furthermore, the results of this study suggest that placental pathology may be related to fetal loss, and placental function should be carefully assessed in fetal-demise cases related to ZIKV infection.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41591-018-0088-5.
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Methods Care and use of nonhuman primates. All macaque monkeys used in this study were cared for by staff at their respective primate centers, in accordance with the regulations and guidelines outlined in the Animal Welfare Act and the Guide for the Care and Use of Laboratory Animals. Each study received approval by the relevant institution's Animal Care and Use Committee. Additional details on the animals in this study are summarized in Supplementary Table 3 .
WNPRC. University of Wisconsin-Madison College of Letters and Sciences and Vice Chancellor for Research and Graduate Education Centers Institutional
Animal Care and Use Committee (animal care and use protocol numbers G005401 and G005246). WaNPRC. University of Washington Institutional Animal Care and Use Committee (numbers 4165-02 and 4202-02).
SNPRC. Texas Biomedical Research Institute Animal Care and Use Committee (protocol number 1528CJ).
ZIKV infections. WNPRC. ZIKV strain H/PF/2013 (GenBank KJ776791), originally isolated from a 51-year-old female in France returning from French Polynesia, with a single round of amplification on Vero cells, was obtained from X. de Lamballerie (European Virus Archive, Marseille France). ZIKV strain PRVABC59 (ZIKV-PR; GenBank KU501215), originally isolated from a traveler to Puerto Rico, with three rounds of amplification on Vero cells, was obtained from B. Russell (CDC, Fort Collins, Colorado, USA). For each inoculation, the stock was thawed, diluted in PBS to the appropriate concentration for each challenge, and loaded into a 1-ml syringe that was kept on ice until challenge. Then 1 ml of inocula was administered through an SC route over the cranial dorsum. At the conclusion of the procedure, animals were closely monitored by veterinary and animal-care staff for adverse reactions and signs of disease.
CNPRC. ZIKV strain ZIKV/H.sapiens-tc/BRA/2015/Brazil_SPH2015 was isolated from Brazil in 2015 (GenBank KU321639.1), as previously described 25 . ZIKV strain PRVABC59 was obtained from WNPRC. Aliquots were stored in liquid nitrogen and thawed immediately before each inoculation procedure. The inoculum was adjusted to the proper number of plaque-forming units (PFU) with RPMI1640 medium to a final volume of 0.5-1 ml for administration to the pregnant dam through the IA, IV, or SC routes. For animals that received both IA and IV administration, the value of PFU listed in Supplementary Table 1 represents the total dose, divided in half for each route; when viral mixtures were used, equal amounts of each virus (in PFU) were used.
ONPRC. Viral preparation and inoculation were as previously described 18 : ZIKV PRVABC59 was obtained from the CDC and passaged twice in C6/36 cells (American Type Culture Collection (ATCC)). Infected C6/36 tissue culture supernatant was concentrated through a 20% sorbitol cushion and titrated in Vero cells (ATCC) through a focus-formation assay. Animals were subjected to SC inoculation in the hand, wrist, and forearm. Each animal received a total inoculum of 1 × 10 5 PFU diluted in PBS to a volume of 1 ml.
TNPRC. ZIKV PRVABC59 was obtained from WNPRC and was prepared as described above. All animals were challenged via SC inoculation with 10,000 PFU of virus.
WaNPRC. We used the following isolates: ZIKV strain isolated in Cambodia (FSS13025, 2010, GenBank KU955593) and ZIKV strain isolated in Fortaleza, Brazil (Brazil 2015 (Fortaleza), GenBank KX811222. ZIKV was inoculated through an SC route at five separate locations on the forearms, each with 10 7 PFU.
SNPRC. Pregnant marmoset dams were infected intramuscularly with two inoculums of ZIKV strain ZIKV/H.sapiens-tc/BRA/2015/Brazil_SPH2015 (GenBank KU321639.1) (Cunha, 2016, Genome Announcements), with each inoculum containing 2.5 × 10 5 PFU of P3 (passage 3 in Vero cells) virus diluted in PBS to a volume of 1 ml. The two inoculums were administered on GD 79 and GD 83 for dam 1 (human equivalent = 14 weeks) or GD 68 and GD 72 for dam 2 (human equivalent = 9 weeks). The P3 viral inoculum was deep-sequenced to > 100× coverage on an Illumina MiSeq instrument, and the assembled consensus sequence was identical to the reference sequence in GenBank.
Details on ZIKV infections are also summarized in Supplementary Table 3 .
Determination of fetal loss. WNPRC. In cases of miscarriage, fetal loss was detected according to the absence of a fetal heartbeat during normal weekly ultrasound examination. In one case, the miscarried fetus was found after it had begun to be expelled from the dam. For stillbirth cases, the fetal loss was discovered during the C-section and was confirmed by a lack of vital responses.
CNPRC. In five of the seven cases, fetal loss was determined according to the absence of a fetal heartbeat during normal ultrasound examination. In one case, fetal loss at GD 115 was observed as severe vaginal bleeding and cervical dilation as signs of imminent abortion. One stillbirth was a nonresponsive neonate found in the morning after spontaneous overnight vaginal delivery.
ONPRC. In dams with pregnancies that were intended to continue to near term (24002, 24005, 25689, 27865, 29806, and 26914), labor readiness was assessed through digital cervical examination by using parameters of cervical ripening in the rhesus macaque, as described by Golub et al. 26 . In the case of dam 24005 with preterm premature rupture of membranes, the cervix was found to be soft and effaced to < 1.5 cm in length, and the outer os was dilated to 1.5 cm in digital examination at GD 113. A high degree of labor readiness was assessed, but pregnancy was allowed to continue because the infant was not yet of viable gestational age. On GD 118, a large volume of clear fluid was noted in the animal's cage pan. Leakage of water into the cage pan from washing or a malfunctioning ad libitum water valve was ruled out, and veterinary staff determined that membrane rupture was the likely source of the fluid. The animal was taken for an emergency Cesarean section the same day to prevent ascending infection or autolysis of fetal tissues; the infant was alive at delivery but nonviable, owing to early gestational age, and was euthanized. In digital examination at GD 122, the cervix of dam 24002 was soft and effaced to < 2 cm in length, and the inner os was dilated 1.5 cm; Cesarean delivery was urgently moved up to GD 126. The infant was successfully resuscitated after delivery but died on GD 128 after sudden cardiorespiratory arrest. Dam 25689 had no premature cervical ripening. The infant was delivered by scheduled Cesarean section on GD 145 and was euthanized 17 d after birth, because of progressive cardiomegaly and tachypnea.
TNPRC. Animals were monitored through monthly clinical evaluation including physical exam, ultrasound, complete blood counts, and serum biochemistry. The viability of the fetus was monitored by measurement of the heart rate during ultrasound examination.
SNPRC. Marmosets received regular ultrasound exams after inoculation. All fetuses were alive during all exams, on the basis of the presence of a fetal heartbeat. Aborted placenta and fetuses were recovered, thus documenting the timing of fetal loss.
WaNPRC. Fetal viability was routinely checked during scheduled ultrasound scans and at the time of Cesarean section. Ultrasounds were performed weekly in this study. At the time of the Cesarean section, the umbilical cord was manually palpated, and pulsation was noted to confirm viability before fetal euthanasia.
Tests performed on the blood and amniotic-fluid samples collected. WNPRC. Blood samples collected were processed for plasma and used to monitor viral load and ZIKV serology in the dams. These viral-load data are available at https://zika. labkey.com/multisite-fetal-demise.url for fetal-loss cases. Amniotic-fluid samples were also collected to monitor viral load. These data are also available through the provided URL.
CNPRC. Blood samples were processed for plasma and used to monitor viral loads in the dams (viral-load data available at https://zika.labkey.com/multisitefetal-demise.url for fetal-loss cases). Amniotic-fluid samples were also collected to monitor viral load and also to regularly perform cytospin with Giemsa staining (detailed data available at https://zika.labkey.com/multisite-fetal-demise.url). TNPRC. Blood and amniotic fluid were collected and tested for ZIKV RNA.
ONPRC
SNPRC. Blood was collected and tested for ZIKV RNA, serology, multiplex cytokine analysis, and transcriptome analysis. Results have been published in ref. 15 .
WaNPRC. Blood and amniotic fluid were tested for ZIKV serology and viral RNA.
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